{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:50:46Z","timestamp":1789681846830,"version":"4.0.1"},"reference-count":318,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Alzheimer's disease (AD) is the leading cause of dementia worldwide and represents a growing public health challenge in aging societies. Despite extensive research efforts, currently approved therapies provide only limited symptomatic benefit and do not halt disease progression. A major obstacle to effective treatment is the blood\u2013brain barrier (BBB), which severely restricts the brain delivery of most therapeutic agents. Nanoparticle-based drug delivery systems have emerged as a promising strategy to overcome BBB-related limitations by enabling precise control over physicochemical properties such as size, surface characteristics, and material composition. These properties can improve drug solubility, stability, pharmacokinetics, and targeted brain accumulation while reducing systemic toxicity. However, efficient BBB penetration and clinically feasible translation remain major challenges. This review summarizes key design principles for nanoparticles intended for AD therapy and highlights representative platforms with translational considerations, particularly lipid-based and polymer-based nanoparticles. In addition, alternative delivery strategies\u2014including nose-to-brain nanoparticle systems and nanoparticles exploiting receptor-mediated and adsorptive-mediated transcytosis, as well as synaptic dysfunction targeting\u2014are discussed. Collectively, this review outlines current advances and future directions for nanoparticle-mediated therapeutic delivery in AD.<\/jats:p>","DOI":"10.3389\/fnins.2026.1810486","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:34:50Z","timestamp":1778736890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Overcoming the blood\u2013brain barrier in Alzheimer's disease: translational perspectives on advanced drug delivery platforms"],"prefix":"10.3389","volume":"20","author":[{"given":"Napaporn","family":"Roamcharern","sequence":"first","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde","place":["Glasgow, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruedeemars","family":"Yubolphan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jfda.2014.10.008","article-title":"Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review","volume":"23","author":"Abd Elgadir","year":"2015","journal-title":"J. Food Drug Anal."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1007\/s12035-020-02013-1","article-title":"Extracellular vesicles of Alzheimer's disease patients as a biomarker for disease progression","volume":"57","author":"Aharon","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biochi.2019.02.012","article-title":"Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles","volume":"160","author":"Ahmad","year":"2019","journal-title":"Biochimie"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/nano10081590","article-title":"A peptide-based nanocarrier for an enhanced delivery and targeting of flurbiprofen into the brain for the treatment of Alzheimer's disease: an in vitro study","volume":"10","author":"Al-Azzawi","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5025341","DOI":"10.1155\/2023\/5025341","article-title":"Study on the physicochemical properties of chitosan and their applications in the biomedical sector","volume":"2023","author":"Alemu","year":"2023","journal-title":"Int. J. Polym. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.3390\/ijms26125541","article-title":"Beyond transgenic mice: emerging models and translational strategies in Alzheimer's disease","volume":"26","author":"Alexandra Lopes","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10876-023-02531-7","article-title":"Donepezil and embelin loaded nanostructured lipid carriers for direct brain delivery as an intervention for alzheimer's disease: formulation design, optimization and evaluation","volume":"35","author":"Ali","year":"2024","journal-title":"J. Clust. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16288","DOI":"10.3390\/ijms242216288","article-title":"Blood\u2013brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1021\/acsptsci.5c00153","article-title":"Crossing barriers: advancements in macromolecular therapeutics for neurodegenerative diseases and strategies to overcome the blood-brain barrier","volume":"8","author":"Alo","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/IJN.S52236","article-title":"Nanoscale drug delivery systems and the blood\u2013brain barrier","volume":"9","author":"Alyautdin","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neuroscience.2025.12.053","article-title":"Antibody drug conjugates in Alzheimer's disease: emerging strategies and future directions","volume":"596","author":"Amelimojarad","year":"2025","journal-title":"Neuroscience"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.1039\/C7NR00772H","article-title":"Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer's disease","volume":"9","author":"Amin","year":"2017","journal-title":"Nanoscale"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1021\/acschemneuro.1c00540","article-title":"Engineered solid lipid nanoparticles and nanostructured lipid carriers as new generations of blood\u2013brain barrier transmitters","volume":"12","author":"Amiri","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood\u2013brain barrier for effective treatment of Alzheimer's disease","volume":"18","author":"Arora","year":"2020","journal-title":"Mol. Pharm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2495632","DOI":"10.1080\/17590914.2025.2495632","article-title":"P-glycoprotein and Alzheimer's disease: threats and opportunities","volume":"17","author":"Asante","year":"2025","journal-title":"ASN Neuro"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.2174\/0929867331666230727103553","article-title":"Aducanumab in Alzheimer's disease: a critical update","volume":"31","author":"Ashique","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/cben.202300027","article-title":"Kinetic modeling to explain the release of medicine from drug delivery systems","volume":"10","author":"Askarizadeh","year":"2023","journal-title":"ChemBioEng Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"113595","DOI":"10.1016\/j.jconrel.2025.113595","article-title":"Mechanisms of receptor-mediated transcytosis at the blood-brain barrier","volume":"381","author":"Baghirov","year":"2025","journal-title":"J. Control. Release"},{"key":"B21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14283\/jpad.2022.21","article-title":"Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with anti-amyloid beta therapy","volume":"9","author":"Barakos","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781119450467.ch1","article-title":"\u201cSources of chitin and chitosan and their isolation,\u201d","volume-title":"Chitin and Chitosan: Properties and Applications","author":"Bastiaens","year":"2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2217\/nnm-2017-0022","article-title":"The effect of nanoparticle size on the ability to cross the blood\u2013brain barrier: an in vivo study","volume":"12","author":"Betzer","year":"2017","journal-title":"Nanomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2174\/1385272827666221027103050","article-title":"Extravaganza of nanobiotechnology in the diagnosis and treatment of dementia patients","volume":"24","author":"Bhattacharya","year":"2023","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ma15030804","article-title":"Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1038\/s41467-024-48461-4","article-title":"Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles","volume":"15","author":"Bian","year":"2024","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J. Exp. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/biomedicines13061464","article-title":"Next-generation drug delivery for neurotherapeutics: the promise of stimuli-triggered nanocarriers","volume":"13","author":"Boyuklieva","year":"2025","journal-title":"Biomedicines"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/acsbiomaterials.0c00743","article-title":"Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood\u2013brain barrier","volume":"6","author":"Brown","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1909999","DOI":"10.1002\/adfm.201909999","article-title":"Endo\/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer's disease","volume":"30","author":"Cai","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"B31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1039\/D2TB02001G","article-title":"Physicochemical properties, pharmacokinetics, toxicology and application of nanocarriers","volume":"11","author":"Cai","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-180098","article-title":"Role of blood-brain barrier in Alzheimer's disease","volume":"63","author":"Cai","year":"2018","journal-title":"J. Alzheimers. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"20230037","DOI":"10.1002\/EXP.20230037","article-title":"Deformable nanocarriers for enhanced drug delivery and cancer therapy","volume":"4","author":"Cao","year":"2024","journal-title":"Exploration"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","article-title":"Nanoparticle crossing of blood\u2013brain barrier: a road to new therapeutic approaches to central nervous system diseases","volume":"13","author":"Ce\u00f1a","year":"2018","journal-title":"Nanomedicine"},{"key":"B35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1201\/9781003164739-27","article-title":"\u201cRegulatory guidelines of the US food and drug administration and the european medicines agency for actively targeted nanomedicines,\u201d","volume-title":"Drug Delivery with Targeted Nanoparticles","author":"\u00c7etinta\u015f","year":"2021"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuroscience.2021.08.003","article-title":"Magnetic resonance imaging of blood-brain barrier permeability in dementia","volume":"474","author":"Chagnot","year":"2021","journal-title":"Neuroscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10311-018-00841-1","article-title":"Nanocarriers for drug delivery applications","volume":"17","author":"Chamundeeswari","year":"2019","journal-title":"Environ. Chem. Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3390\/pharmaceutics15092316","article-title":"A promising approach: magnetic nanosystems for alzheimer's disease theranostics","volume":"15","author":"Chaparro","year":"2023","journal-title":"Pharmaceutics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.3390\/ijms24032710","article-title":"Experimental models of in vitro blood\u2013brain barrier for CNS drug delivery: an evolutionary perspective","volume":"24","author":"Chaulagain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/03639045.2023.2252062","article-title":"ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer's disease in APP\/PS-1 mice","volume":"49","author":"Chen","year":"2023","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","article-title":"Synaptic dysfunction in Alzheimer's disease: mechanisms and therapeutic strategies","volume":"195","author":"Chen","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1258640","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer's disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jconrel.2024.07.010","article-title":"Pantothenate-encapsulated liposomes combined with exercise for effective inhibition of CRM1-mediated PKM2 translocation in Alzheimer's therapy","volume":"373","author":"Chen","year":"","journal-title":"J. Control. Release"},{"key":"B44","doi-asserted-by":"publisher","first-page":"113604","DOI":"10.1016\/j.jconrel.2025.113604","article-title":"A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer's disease combination therapy","volume":"381","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"key":"B45","doi-asserted-by":"publisher","first-page":"115196","DOI":"10.1016\/j.addr.2024.115196","article-title":"Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway","volume":"207","author":"Chen","year":"","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1021\/acs.molpharmaceut.3c00180","article-title":"Shape and shear stress impact on the toxicity of mesoporous silica nanoparticles: in vitro and in vivo evidence","volume":"20","author":"Cheng","year":"2023","journal-title":"Mol. Pharmaceutics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1080\/17425247.2023.2286371","article-title":"Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery","volume":"20","author":"Choi","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"B48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3233\/JCB-15020","article-title":"Strategies to enhance nanoparticle-endothelial interactions under flow","volume":"1","author":"Cicha","year":"2016","journal-title":"J. Cell. Biotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"B50","first-page":"63","article-title":"\u201cZeta potential measurement,\u201d","volume-title":"Characterization of Nanoparticles Intended for Drug Delivery","author":"Clogston","year":"2010"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2000948","DOI":"10.1002\/adhm.202000948","article-title":"Analysis of the human plasma proteome using multi-nanoparticle protein corona for detection of Alzheimer's disease","volume":"10","author":"Corbo","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"128088","DOI":"10.1016\/j.polymer.2025.128088","article-title":"Enhancing degradation resistance of polyglycolic acid through stereocomplex polylactic acid integration: a novel \u201cstereo-lock\u201d approach","volume":"321","author":"Cui","year":"2025","journal-title":"Polymer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer's disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimers. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2410030","DOI":"10.1002\/smll.202410030","article-title":"Stimuli-responsive nano drug delivery systems for the treatment of neurological diseases","volume":"21","author":"Dai","year":"2025","journal-title":"Small"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10856-008-3666-0","article-title":"Size effect of PLGA spheres on drug loading efficiency and release profiles","volume":"20","author":"Dawes","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/bioengineering11020167","article-title":"Silk fibroin materials: biomedical applications and perspectives","volume":"11","author":"De Giorgio","year":"2024","journal-title":"Bioengineering"},{"key":"B58","doi-asserted-by":"publisher","first-page":"121367","DOI":"10.1016\/j.ijpharm.2021.121367","article-title":"Therapeutic nanoparticles in the brain: a review of types, physicochemical properties and challenges","volume":"612","author":"De Lima","year":"2022","journal-title":"Int. J. Pharm."},{"key":"B59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2105373","DOI":"10.1002\/advs.202105373","article-title":"Structure-based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles","volume":"9","author":"De","year":"2022","journal-title":"Adv. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4155\/fmc.12.51","article-title":"Is RAGE still a therapeutic target for Alzheimer's disease?","volume":"4","author":"Deane","year":"2012","journal-title":"Future Med. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/app11094305","article-title":"Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer's disease","volume":"11","author":"Del Amo","year":"2021","journal-title":"Appl. Sci."},{"key":"B63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-031-72467-1_8","article-title":"\u201cNanomedicine in targeted drug delivery: precision therapeutics for personalized medicine,\u201d","volume-title":"Nanomedicine: Innovations, Applications, and Breakthroughs in the Quest for Health and Medicine's Future","author":"Dey","year":"2024"},{"key":"B64","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/cpt.2954","article-title":"Physician perspectives on the Food and Drug Administration's decision to grant accelerated approval to aducanumab for Alzheimer's disease","volume":"114","author":"Dhruva","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/pharmaceutics16010058","article-title":"Intranasal drug delivery by nanotechnology: advances in and challenges for Alzheimer's disease management","volume":"16","author":"Dighe","year":"2023","journal-title":"Pharmaceutics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s11671-025-04303-w","article-title":"Emerging trends in synthesis, characterization, and mechanism of action of antibody-drug and antibody-nanoparticle conjugates","volume":"20","author":"Dixit","year":"2025","journal-title":"Discov. Nano"},{"key":"B67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-031-23112-4_11","article-title":"\u201cNovel mucoadhesive polymers for nasal drug delivery,\u201d","volume-title":"Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions","author":"Djekic","year":"2023"},{"key":"B68","doi-asserted-by":"publisher","first-page":"984252","DOI":"10.3389\/fimmu.2022.984252","article-title":"Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory","volume":"13","author":"Dobrovolskaia","year":"2022","journal-title":"Front. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10876-025-02798-y","article-title":"Intranasal poly (lactic-co-glycolic acid) nanoparticles of mefenamic acid improve motor expressions and neurochemical injury in aluminium chloride originated Alzheimer's disease","volume":"36","author":"Dogra","year":"2025","journal-title":"J. Cluster Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1208\/s12249-023-02727-0","article-title":"Mefenamic acid loaded and TPGS stabilized mucoadhesive nanoemulsion for the treatment of Alzheimer's disease: development, optimization, and brain-targeted delivery via olfactory pathway","volume":"25","author":"Dogra","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1326784","DOI":"10.3389\/fnins.2024.1326784","article-title":"Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications","volume":"18","author":"Doran","year":"2024","journal-title":"Front. Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jconrel.2024.06.005","article-title":"PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting","volume":"372","author":"Du","year":"2024","journal-title":"J. Control. Release"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"key":"B74","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12031-025-02432-6","article-title":"Exosome\/extracellular vesicles-based therapeutics in Alzheimer's disease: neuroprotective roles and future perspectives","volume":"75","author":"Ebadpour","year":"2025","journal-title":"J. Mol. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuroscience.2025.10.011","article-title":"Anti-amyloid monoclonal antibody therapies in Alzheimer's disease \u2013 a scoping review","volume":"589","author":"Elamin","year":"2025","journal-title":"Neuroscience"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/jps.24557","article-title":"Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer's disease: optimization, biological efficacy, and potential toxicity","volume":"104","author":"Elnaggar","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1039\/C5BM00052A","article-title":"Protein nanoparticles for therapeutic protein delivery","volume":"3","author":"Estrada","year":"2015","journal-title":"Biomater. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1002\/wnan.1798","article-title":"Understanding the immunological interactions of engineered nanomaterials: role of the bio-corona","volume":"14","author":"Fadeel","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018024697","article-title":"Updated progress of nanocarrier-based intranasal drug delivery systems for treatment of brain diseases","volume":"35","author":"Fan","year":"2018","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"B80","doi-asserted-by":"publisher","first-page":"14499","DOI":"10.3390\/ijms241914499","article-title":"Anti-amyloid therapies for Alzheimer's disease and the amyloid cascade hypothesis","volume":"24","author":"Fedele","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1021\/acschemneuro.5c00484","article-title":"Antibody therapies for Alzheimer's disease: a new strategy for targeted therapy and blood\u2013brain barrier delivery","volume":"16","author":"Feng","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","article-title":"Intranasal drug delivery for treatment of Alzheimer's disease","volume":"11","author":"Fonseca","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.apmt.2022.101631","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"B84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.irn.2016.06.001","article-title":"From the blood to the central nervous system: a nanoparticle's journey through the blood-brain barrier by transcytosis","volume":"130","author":"Fullstone","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.3390\/ijms23169237","article-title":"Bisdemethoxycurcumin (BDC)-loaded H-ferritin-nanocages mediate the regulation of inflammation in Alzheimer's disease patients","volume":"23","author":"Gagliardi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"110770","DOI":"10.1016\/j.colsurfb.2019.110770","article-title":"PEGylated nanocarriers: a promising tool for targeted delivery to the brain","volume":"187","author":"Gajbhiye","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12035-025-05320-7","article-title":"Breaking the Alzheimer's treatment stalemate: synergistic application strategies of nanomaterials and pharmaceutical agents","volume":"63","author":"Gao","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.2147\/IJN.S549893","article-title":"Nanotechnology for neurodegenerative diseases: recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics","volume":"20","author":"Gao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/molecules29153580","article-title":"Advances in brain stimulation, nanomedicine and the use of magnetoelectric nanoparticles: dopaminergic alterations and their role in neurodegeneration and drug addiction","volume":"29","author":"Gim\u00e9nez","year":"2024","journal-title":"Molecules"},{"key":"B90","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/1073858420954811","article-title":"Cerebral amyloid angiopathy and blood-brain barrier dysfunction","volume":"27","author":"Gireud-Goss","year":"2021","journal-title":"Neuroscientist"},{"key":"B91","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/pharmaceutics17050661","article-title":"Advancing brain targeting: cost-effective surface-modified nanoparticles for faster market entry","volume":"17","author":"Gomes","year":"2025","journal-title":"Pharmaceutics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2400149","DOI":"10.1002\/adhm.202400149","article-title":"Systemic administration of neurotransmitter-derived Lipidoids-PROTACs-DNA nanocomplex promotes tau clearance and cognitive recovery for Alzheimer's disease therapy","volume":"13","author":"Gong","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"B93","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2019.12.034","article-title":"Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: role of surface engineered nanocarriers","volume":"319","author":"Gopalan","year":"2020","journal-title":"J. Control. Release"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1021\/acs.molpharmaceut.3c00031","article-title":"Multifunctionalized cationic chitosan polymeric micelles polyplexed with pvgf for noninvasive delivery to the mouse brain through the intranasal route for developing therapeutics for alzheimer's disease","volume":"20","author":"Gothwal","year":"2023","journal-title":"Mol. Pharm."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2261509","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"MAbs"},{"key":"B96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5582\/bst.2023.01288","article-title":"Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets","volume":"18","author":"Gu","year":"2024","journal-title":"Biosci. Trends"},{"key":"B97","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2020.03.009","article-title":"Clearance of two organic nanoparticles from the brain via the paravascular pathway","volume":"322","author":"Gu","year":"2020","journal-title":"J. Control. Release"},{"key":"B98","doi-asserted-by":"publisher","first-page":"115538","DOI":"10.1016\/j.colsurfb.2026.115538","article-title":"Apolipoprotein E-enriched protein corona enhances the blood-brain barrier transport of \u03b2-sheet-breaker peptide-functionalized gold nanoparticles","volume":"262","author":"Guerrero","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/ma11071154","article-title":"Surface modifications of nanoparticles for stability in biological fluids","volume":"11","author":"Guerrini","year":"2018","journal-title":"Materials"},{"key":"B100","doi-asserted-by":"publisher","first-page":"10244","DOI":"10.1021\/ja303280r","article-title":"Cholinesterase-responsive supramolecular vesicle","volume":"134","author":"Guo","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"B101","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jconrel.2020.01.039","article-title":"A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice","volume":"320","author":"Guo","year":"2020","journal-title":"J. Control. Release"},{"key":"B102","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1021\/acsnano.1c00658","article-title":"Nanoparticle-enabled enrichment of longitudinal blood proteomic fingerprints in Alzheimer's disease","volume":"15","author":"Hadjidemetriou","year":"2021","journal-title":"ACS Nano"},{"key":"B103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40263-020-00781-x","article-title":"Intranasal insulin for Alzheimer's disease","volume":"35","author":"Hallschmid","year":"2021","journal-title":"CNS Drugs"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s42995-023-00172-3","article-title":"The neuroprotective effects of peracetylated chitosan oligosaccharides against \u03b2-amyloid-induced cognitive deficits in rats","volume":"5","author":"Hao","year":"2023","journal-title":"Mar. Life Sci. Technol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1360302","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Front. Drug Deliv."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e70176","DOI":"10.1111\/jnc.70176","article-title":"Alzheimer's disease: treatment challenges for the future","volume":"169","author":"Hardy","year":"2025","journal-title":"J. Neurochem."},{"key":"B108","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"B109","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.addr.2010.09.001","article-title":"A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma","volume":"63","author":"Hatakeyama","year":"","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B110","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1016\/j.biomaterials.2011.02.045","article-title":"Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid","volume":"32","author":"Hatakeyama","year":"","journal-title":"Biomaterials"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4103\/1673-5374.327328","article-title":"Liposome based drug delivery as a potential treatment option for Alzheimer's disease","volume":"17","author":"Hernandez","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herve","year":"2008","journal-title":"AAPS J."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1800465","DOI":"10.1002\/adhm.201800465","article-title":"The biomedical use of silk: past, present, future","volume":"8","author":"Holland","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"B115","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/pharmaceutics13040587","article-title":"Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers","volume":"13","author":"Iacob","year":"2021","journal-title":"Pharmaceutics"},{"key":"B116","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fnins.2019.00735","article-title":"Targeting the synapse in Alzheimer's disease","volume":"13","author":"Jackson","year":"2019","journal-title":"Front. Neurosci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.colsurfa.2017.10.059","article-title":"Structural changes on polymeric nanoparticles induced by hydrophobic drug entrapment","volume":"538","author":"J\u00e4ger","year":"2018","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"B118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12951-025-03109-3","article-title":"Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment","volume":"23","author":"Jang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.bioactmat.2020.11.024","article-title":"Legumain-induced intracerebrally crosslinked vesicles for suppressing efflux transport of Alzheimer's disease multi-drug nanosystem","volume":"6","author":"Jiang","year":"2021","journal-title":"Bioact. Mater."},{"key":"B120","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/03639040903170750","article-title":"The application of mucoadhesive polymers in nasal drug delivery","volume":"36","author":"Jiang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B121","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","article-title":"Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer's disease","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"B122","doi-asserted-by":"publisher","first-page":"13077","DOI":"10.1007\/s12274-023-6026-y","article-title":"Intranasal administration nanosystems for brain-targeted drug delivery","volume":"16","author":"Jiang","year":"2023","journal-title":"Nano Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1800039","DOI":"10.1002\/ejlt.201800039","article-title":"Comparative effects of cholesterol and \u03b2-sitosterol on the liposome membrane characteristics","volume":"120","author":"Jovanovi\u0107","year":"2018","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1039\/D3RA07634B","article-title":"Functionalising silk hydrogels with hetero-and homotypic nanoparticles","volume":"14","author":"Kaewchuchuen","year":"2024","journal-title":"RSC Adv."},{"key":"B126","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/wnan.1389","article-title":"pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents","volume":"8","author":"Karimi","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"20045","DOI":"10.1039\/C9NR04795F","article-title":"Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours","volume":"11","author":"Karlsson","year":"2019","journal-title":"Nanoscale"},{"key":"B128","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coche.2020.07.002","article-title":"In vitro models of the blood-brain barrier: building in physiological complexity","volume":"30","author":"Katt","year":"2020","journal-title":"Curr. Opin. Chem. Eng."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1840913","DOI":"10.1080\/21688370.2020.1840913","article-title":"Basic physiology of the blood-brain barrier in health and disease: a brief overview","volume":"9","author":"Kaya","year":"2021","journal-title":"Tissue Barriers"},{"key":"B130","doi-asserted-by":"publisher","first-page":"240","DOI":"10.14283\/jpad.2021.14","article-title":"Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and Alzheimer's disease","volume":"8","author":"Kellar","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s11671-025-04276-w","article-title":"Nose to brain delivery of nanostructured lipid carriers loaded with rivastigmine and nilotinib for treating Alzheimer's disease: preparation, cell line study, and in vivo evaluation","volume":"20","author":"Khan","year":"2025","journal-title":"Discover Nano"},{"key":"B133","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4161\/mabs.2.6.13333","article-title":"Charge variants in IgG1: isolation, characterization, in vitro binding properties and pharmacokinetics in rats","volume":"2","author":"Khawli","year":"2010","journal-title":"MAbs"},{"key":"B134","doi-asserted-by":"publisher","first-page":"7877265","DOI":"10.1155\/2024\/7877265","article-title":"Development, statistical optimization, and characterization of resveratrol-containing solid lipid nanoparticles (SLNs) and determination of the efficacy in reducing neurodegenerative symptoms related to Alzheimer's disease: in vitro and in vivo study","volume":"2024","author":"Khishvand","year":"2024","journal-title":"Biomed Res. Int."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1201\/9781003482826-1","article-title":"\u201cChallenges for commercial translation of nanomedicines: from lab scale to production scale,\u201d","author":"Khopade","year":"2025","journal-title":"Commercial Scale Production of Nanomedicines"},{"key":"B136","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"B137","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12035-025-05417-z","article-title":"Targeted nanoparticles for drug delivery across the blood\u2013brain barrier in early and late stages of Alzheimer's disease: a review","volume":"63","author":"Kochman","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate Alzheimer's disease-related pathology in APP\/PS-1 mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B139","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijbiomac.2020.12.005","article-title":"Chitosan: a review of sources and preparation methods","volume":"169","author":"Kou","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"key":"B141","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-818415-8.00007-3","article-title":"\u201cPoly(lactic acid) and poly(lactic-co-glycolic) acid nanoparticles: versatility in biomedical applications,\u201d","volume-title":"Materials for Biomedical Engineering","author":"Kumar","year":"2019"},{"key":"B142","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/1061186X.2014.965716","article-title":"Targeting delivery of liposomes with conjugated p-aminophenyl-\u03b1-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with \u03b2-amyloid peptide","volume":"23","author":"Kuo","year":"2015","journal-title":"J. Drug Target."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.2147\/IJN.S132472","article-title":"Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin","volume":"12","author":"Kuo","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1908473","DOI":"10.1002\/adfm.201908473","article-title":"Engineering versatile nanoparticles for near-infrared light-tunable drug release and photothermal degradation of amyloid \u03b2","volume":"30","author":"Lai","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"B145","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"key":"B146","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","article-title":"Controlled drug release from pharmaceutical nanocarriers","volume":"125","author":"Lee","year":"2015","journal-title":"Chem. Eng. Sci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jconrel.2011.07.028","article-title":"Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes","volume":"155","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1144036","DOI":"10.3389\/fnagi.2023.1144036","article-title":"Imaging blood\u2013brain barrier disruption in neuroinflammation and Alzheimer's disease","volume":"15","author":"Lee","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1039\/D5BM01582K","article-title":"Translational roadmap of BBB-targeted nanoparticle strategies for neuroregenerative therapy in neurodegenerative diseases","volume":"14","author":"Lee","year":"2026","journal-title":"Biomater. Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"117011","DOI":"10.1016\/j.biopha.2024.117011","article-title":"Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: challenges and opportunities","volume":"177","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1039\/D5PM00148J","article-title":"Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer's disease treatment","volume":"2","author":"Li","year":"2025","journal-title":"RSC Pharm."},{"key":"B152","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1533\/9780857097064.2.330","article-title":"\u201cBiodegradation behavior of silk biomaterials,\u201d","volume-title":"Silk Biomaterials for Tissue Engineering and Regenerative Medicine","author":"Li","year":"2014"},{"key":"B153","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/9780470110546.ch7","article-title":"Liposomes: preparation, characterization, and preservation","volume":"33","author":"Lichtenberg","year":"1988","journal-title":"Methods Biochem. Anal."},{"key":"B154","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/pharmaceutics14030614","article-title":"Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development","volume":"14","author":"Lim","year":"2022","journal-title":"Pharmaceutics"},{"key":"B155","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","article-title":"Updates in Alzheimer's disease: from basic research to diagnosis and therapies","volume":"13","author":"Liu","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"B156","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","article-title":"Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"B157","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/cplu.202000496","article-title":"Development of high-drug-loading nanoparticles","volume":"85","author":"Liu","year":"2020","journal-title":"ChemPlusChem"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2174\/1381612826666200218101231","article-title":"Lipid nanoparticles as carriers for the treatment of neurodegeneration associated with Alzheimer's disease and glaucoma: present and future challenges","volume":"26","author":"L\u00f3pez","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"B160","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/ph16030454","article-title":"Properties of poly (lactic-co-glycolic acid) and progress of poly (lactic-co-glycolic acid)-based biodegradable materials in biomedical research","volume":"16","author":"Lu","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B161","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1039\/D4TB02616K","article-title":"Application of silk fibroin-based composite films in biomedicine and biotechnology","volume":"13","author":"Ma","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"B162","doi-asserted-by":"publisher","first-page":"121065","DOI":"10.1016\/j.biomaterials.2021.121065","article-title":"Near-infrared target enhanced peripheral clearance of amyloid-\u03b2 in Alzheimer's disease model","volume":"276","author":"Ma","year":"2021","journal-title":"Biomaterials"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e24304","DOI":"10.1016\/j.heliyon.2024.e24304","article-title":"Accurate prediction of Kp, uu, brain based on experimental measurement of Kp, brain and computed physicochemical properties of candidate compounds in CNS drug discovery","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"key":"B164","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1021\/acs.molpharmaceut.5c00056","article-title":"Roadmap for commercial nanomedicine development: integrating quality by design principles with pharmaceutical nanotechnology","volume":"22","author":"Maheshwari","year":"2025","journal-title":"Mol. Pharm."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"B166","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.2147\/IJN.S133832","article-title":"Physicochemical characterization of drug nanocarriers","volume":"12","author":"Manaia","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1615764","DOI":"10.3389\/fragi.2025.1615764","article-title":"Pathogenic synergy: dysfunctional mitochondria and neuroinflammation in neurodegenerative diseases associated with aging","volume":"6","author":"Mani","year":"2025","journal-title":"Front. Aging"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbm.b.35006","article-title":"Design and evaluation of nanostructured lipid carriers loaded with Salvia officinalis extract for Alzheimer's disease treatment","volume":"110","author":"Markova","year":"2022","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"B169","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2217\/nnm.10.51","article-title":"Silk fibroin-derived nanoparticles for biomedical applications","volume":"5","author":"Mathur","year":"2010","journal-title":"Nanomedicine"},{"key":"B170","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2174\/1871527321666220420133059","article-title":"Recent Trends in nano-particulate carriers for the diagnosis and treatment of Alzheimer's disease","volume":"22","author":"Mazahir","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B171","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1039\/D1TB02015C","article-title":"Influence of nanoparticle size on blood\u2013brain barrier penetration and the accumulation of anti-seizure medicines in the brain","volume":"10","author":"Meng","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B173","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12035-025-05297-3","article-title":"Neuroprotective role of piperine-encapsulated casein micelles in mitigating intracellular dyshomeostasis in Alzheimer's disease pathology","volume":"63","author":"Mishra","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.2174\/1381612826666200417141600","article-title":"Ligand conjugated targeted nanotherapeutics for treatment of neurological disorders","volume":"26","author":"Mittal","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"B175","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"B176","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12951-024-02897-4","article-title":"Exploring the anti-inflammatory effects of curcumin encapsulated within ferritin nanocages: a comprehensive in vivo and in vitro study in Alzheimer's disease","volume":"22","author":"Morasso","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/pharmaceutics15041054","article-title":"Dendrimers and derivatives as multifunctional nanotherapeutics for Alzheimer's disease","volume":"15","author":"Moreira","year":"2023","journal-title":"Pharmaceutics"},{"key":"B179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1258\/jrsm.2010.100243","article-title":"The history and evolution of sutures in pelvic surgery","volume":"104","author":"Muffly","year":"2011","journal-title":"J. R. Soc. Med."},{"key":"B180","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1021\/acs.molpharmaceut.4c00870","article-title":"Synthesis and characterization of transferrin and cell-penetrating peptide-functionalized liposomal nanoparticles to deliver plasmid ApoE2 in vitro and in vivo in mice","volume":"22","author":"Muolokwu","year":"2024","journal-title":"Mol. Pharm."},{"key":"B181","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/pharmaceutics13040437","article-title":"Evaluation and comparison of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as vectors to develop hydrochlorothiazide effective and safe pediatric oral liquid formulations","volume":"13","author":"Mura","year":"2021","journal-title":"Pharmaceutics"},{"key":"B182","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2217\/nnm-2022-0287","article-title":"Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood\u2013brain barrier for targeted drug delivery","volume":"18","author":"Na","year":"2023","journal-title":"Nanomedicine"},{"key":"B183","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1021\/acs.molpharmaceut.5c00062","article-title":"Revolutionizing neurological therapies: the multifaceted potential of zein-based nanoparticles for brain-targeted drug delivery","volume":"22","author":"Narayan","year":"2025","journal-title":"Mol. Pharm."},{"key":"B184","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2014.05.029","article-title":"Sustained-release from nanocarriers: a review","volume":"193","author":"Natarajan","year":"2014","journal-title":"J. Control. Release"},{"key":"B185","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/pharmaceutics14112296","article-title":"Drug delivery systems as a strategy to improve the efficacy of FDA-approved Alzheimer's drugs","volume":"14","author":"Nunes","year":"2022","journal-title":"Pharmaceutics"},{"key":"B186","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-5173(02)00035-2","article-title":"Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)\u2014effect of surfactants, storage time and crystallinity","volume":"237","author":"Olbrich","year":"2002","journal-title":"Int. J. Pharm."},{"key":"B187","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.2174\/0929867321666140716103130","article-title":"Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders","volume":"21","author":"Ong","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.12.003","article-title":"Toward more predictive genetic mouse models of Alzheimer's disease","volume":"122","author":"Onos","year":"2016","journal-title":"Brain Res. Bull."},{"key":"B189","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1021\/acs.biomac.8b00589","article-title":"Importance of encapsulation stability of nanocarriers with high drug loading capacity for increasing in vivo therapeutic efficacy","volume":"19","author":"Palanikumar","year":"2018","journal-title":"Biomacromolecules"},{"key":"B190","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s11064-020-03076-1","article-title":"Brain microvascular endothelial cell derived exosomes potently ameliorate cognitive dysfunction by enhancing the clearance of A\u03b2 through up-regulation of P-gp in mouse model of AD","volume":"45","author":"Pan","year":"2020","journal-title":"Neurochem. Res."},{"key":"B191","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13195-025-01840-5","article-title":"Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of Alzheimer's disease in a mouse model","volume":"17","author":"Pan","year":"2025","journal-title":"Alzheimers. Res. Ther."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ijbiomac.2020.07.326","article-title":"Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: development, characterization, in-vitro studies","volume":"164","author":"Pandey","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/jps.20094","article-title":"Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA\/PLA nanoparticles","volume":"93","author":"Panyam","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"B195","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"B196","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer's disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B197","doi-asserted-by":"publisher","first-page":"20230137","DOI":"10.1002\/EXP.20230137","article-title":"Tau-targeting nanoparticles for treatment of Alzheimer's disease","volume":"5","author":"Pawar","year":"2025","journal-title":"Exploration"},{"key":"B198","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/pr11020319","article-title":"Dendrimers in neurodegenerative diseases","volume":"11","author":"P\u00e9rez-Carri\u00f3n","year":"2023","journal-title":"Processes"},{"key":"B199","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/pharmaceutics13060770","article-title":"Degradation of drug delivery nanocarriers and payload release: a review of physical methods for tracing nanocarrier biological fate","volume":"13","author":"Perrigue","year":"2021","journal-title":"Pharmaceutics"},{"key":"B200","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1021\/jacs.5b13153","article-title":"Surface charge visualization at viable living cells","volume":"138","author":"Perry","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"B201","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/pharmaceutics16070948","article-title":"Low-density lipoprotein receptor-related protein 1 as a potential therapeutic target in Alzheimer's disease","volume":"16","author":"Petralla","year":"","journal-title":"Pharmaceutics"},{"key":"B202","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1007\/s12035-024-03990-3","article-title":"Increased expression of transferrin receptor 1 in the brain cortex of 5xFAD mouse model of Alzheimer's disease is associated with activation of HIF-1 signaling pathway","volume":"61","author":"Petralla","year":"","journal-title":"Mol. Neurobiol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jconrel.2014.02.002","article-title":"Process for protein PEGylation","volume":"180","author":"Pfister","year":"2014","journal-title":"J. Control. Release"},{"key":"B204","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/156720510793499066","article-title":"Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-beta clearance in Alzheimer's disease","volume":"7","author":"Pflanzner","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.3390\/ijms26157050","article-title":"Beyond the walls of Troy: a scoping review on pharmacological strategies to enhance drug delivery across the blood-brain barrier and blood-tumor barrier","volume":"26","author":"Pinkiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2026.2628612","article-title":"Advances in mucoadhesive and mucus-penetrating materials, nano-formulations, and in situ gelling systems for nasal drug delivery","author":"Porfiryeva","year":"2026","journal-title":"Expert Opin. Drug Deliv"},{"key":"B207","doi-asserted-by":"publisher","first-page":"110539","DOI":"10.1016\/j.cellsig.2022.110539","article-title":"Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease","volume":"102","author":"Punyakoti","year":"2023","journal-title":"Cell. Signal."},{"key":"B208","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.rechem.2024.101463","article-title":"Breaking the barriers in management of Alzheimer's disease through cationic nanoformulation: a review","volume":"7","author":"Puri","year":"2024","journal-title":"Results Chem."},{"key":"B209","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-025-00515-3","article-title":"Roles of TREM2 in Alzheimer's disease","volume":"14","author":"Qi","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"B210","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1007\/s13346-023-01368-x","article-title":"Combination of micelles and liposomes as a promising drug delivery system: a review","volume":"13","author":"Qian","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"B211","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bioactmat.2021.10.038","article-title":"Uptake of oxidative stress-mediated extracellular vesicles by vascular endothelial cells under low magnitude shear stress","volume":"9","author":"Qin","year":"2022","journal-title":"Bioact. Mater."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0006-3495(99)77363-7","article-title":"Control of lipid membrane stability by cholesterol content","volume":"76","author":"Raffy","year":"1999","journal-title":"Biophys. J."},{"key":"B213","doi-asserted-by":"publisher","first-page":"104756","DOI":"10.1016\/j.jddst.2023.104756","article-title":"Nose-to-brain drug delivery: challenges and progress towards brain targeting in the treatment of neurological disorders","volume":"86","author":"Raghav","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1021\/bm300736m","article-title":"Structure and biodegradation mechanism of milled Bombyx mori silk particles","volume":"13","author":"Rajkhowa","year":"2012","journal-title":"Biomacromolecules"},{"key":"B215","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/21655979.2021.2012907","article-title":"New challenges in the use of nanomedicine in cancer therapy","volume":"13","author":"Rasool","year":"2022","journal-title":"Bioengineered"},{"key":"B216","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"B217","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3171\/2022.9.JNS221565","article-title":"Focused ultrasound\u2013mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes","volume":"139","author":"Rezai","year":"2022","journal-title":"J. Neurosurg."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4103\/1673-5374.255978","article-title":"Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease","volume":"14","author":"Reza-Zaldivar","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1021\/acsbiomaterials.4c02175","article-title":"Biomimetic silk nanoparticle manufacture: calcium ion-mediated assembly","volume":"11","author":"Roamcharern","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B220","doi-asserted-by":"publisher","first-page":"102291","DOI":"10.1016\/j.arr.2024.102291","article-title":"Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies\/systems","volume":"97","author":"Roghani","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B221","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","article-title":"Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer's disease","volume":"108","author":"Roney","year":"2005","journal-title":"J. Control. Release"},{"key":"B222","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.2147\/IJN.S183117","article-title":"Liposome delivery systems for the treatment of Alzheimer's disease","volume":"13","author":"Ross","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"B223","first-page":"339","article-title":"Nanotechnology and the FDA: what are the scientific and regulatory considerations for products containing nanomaterials","volume":"3","author":"Sadrieh","year":"2006","journal-title":"Nanotech. L. Bus."},{"key":"B224","doi-asserted-by":"publisher","first-page":"111838","DOI":"10.1016\/j.colsurfb.2021.111838","article-title":"Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer's disease: a preclinical evidence","volume":"205","author":"Saini","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B225","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/cells9040851","article-title":"Targeting and crossing the blood-brain barrier with extracellular vesicles","volume":"9","author":"Saint-Pol","year":"2020","journal-title":"Cells"},{"key":"B226","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/acs.chas.3c00008","article-title":"Toxicity of polymeric nanodrugs as drug carriers","volume":"30","author":"Sairam","year":"2023","journal-title":"ACS Chem. Health Saf."},{"key":"B227","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12964-023-01142-z","article-title":"Physiological and pathological consequences of exosomes at the blood-brain-barrier interface","volume":"21","author":"Salimi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"B228","doi-asserted-by":"publisher","first-page":"106862","DOI":"10.1016\/j.jddst.2025.106862","article-title":"Intranasal Apocynin-loaded nanostructured lipid carriers (NLCs) for Alzheimer's disease therapy: formulation, optimization, and pharmacokinetic evaluations","volume":"108","author":"Samala","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization","volume":"16","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"key":"B231","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.2174\/0929867323666160607103854","article-title":"Recent trends of biocompatible and biodegradable nanoparticles in drug delivery: a review","volume":"23","author":"Sathish Sundar","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"B232","doi-asserted-by":"publisher","first-page":"13182","DOI":"10.1007\/s12035-025-05137-4","article-title":"Intra-nasal delivery of quercetin-loaded nanostructured lipid carriers (NLCs) in the management of Alzheimer's disease: formulation, in vitro and in vivo assessment","volume":"62","author":"Satpathy","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B234","doi-asserted-by":"publisher","first-page":"100214","DOI":"10.1016\/j.tjpad.2025.100214","article-title":"Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease","volume":"12","author":"Sehlin","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B235","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"B236","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"B237","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B238","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1570159X20666220706121412","article-title":"Nanocarrier-based drug delivery to brain: interventions of surface modification","volume":"21","author":"Sharma","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.2147\/IJN.S417928","article-title":"Combined donepezil with astaxanthin via nanostructured lipid carriers effective delivery to brain for Alzheimer's disease in rat model","volume":"18","author":"Shehata","year":"","journal-title":"Int. J. Nanomedicine"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2147\/IJN.S402447","article-title":"Nose to brain delivery of astaxanthin\u2013loaded nanostructured lipid carriers in rat model of Alzheimer's disease: preparation, in vitro and in vivo evaluation","volume":"18","author":"Shehata","year":"","journal-title":"Int. J. Nanomedicine"},{"key":"B241","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1208\/s12249-024-02923-6","article-title":"Breaking barriers in Alzheimer's disease: the role of advanced drug delivery systems","volume":"25","author":"Shekho","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"B242","doi-asserted-by":"publisher","first-page":"9793","DOI":"10.3390\/ijms26199793","article-title":"Targeting transferrin receptor 1 for enhancing drug delivery through the blood-brain barrier for Alzheimer's disease","volume":"26","author":"Shen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B243","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/pharmaceutics15010221","article-title":"Development and evaluation of solid lipid nanoparticles for the clearance of A\u03b2 in Alzheimer's disease","volume":"15","author":"Shivananjegowda","year":"2023","journal-title":"Pharmaceutics"},{"key":"B244","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neurol.2025.11.005","article-title":"Intranasal insulin for mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"182","author":"Silva","year":"2025","journal-title":"Rev. Neurol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/1061186X.2022.2063297","article-title":"Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease","volume":"30","author":"Singh","year":"2022","journal-title":"J. Drug Target."},{"key":"B246","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release"},{"key":"B247","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/0115672050380959250530112247","article-title":"Advance nanotechnology-based drug delivery systems for Alzheimer's disease: advancements and future perspectives","volume":"22","author":"Singh","year":"2025","journal-title":"Curr. Alzheimer Res."},{"key":"B248","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/ma15062121","article-title":"Long-term clearance and biodistribution of magnetic nanoparticles assessed by AC biosusceptometry","volume":"15","author":"Soares","year":"2022","journal-title":"Materials"},{"key":"B249","doi-asserted-by":"publisher","first-page":"10118","DOI":"10.3390\/ijms221810118","article-title":"Design and development of nanomaterial-based drug carriers to overcome the blood\u2013brain barrier by using different transport mechanisms","volume":"22","author":"Song","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B250","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/1061186X.2013.876644","article-title":"Intranasal therapeutic strategies for management of Alzheimer's disease","volume":"22","author":"Sood","year":"2014","journal-title":"J. Drug Target."},{"key":"B251","doi-asserted-by":"publisher","first-page":"469679","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer\u2032 s disease and Parkinson\u2032 s disease)","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"B252","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40259-018-0309-y","article-title":"Emerging technologies for delivery of biotherapeutics and gene therapy across the blood-brain barrier","volume":"32","author":"Stanimirovic","year":"2018","journal-title":"BioDrugs"},{"key":"B253","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.molstruc.2004.11.075","article-title":"The influence of temperature, cholesterol content and pH on liposome stability","volume":"744","author":"Su\u0142kowski","year":"2005","journal-title":"J. Mol. Struct."},{"key":"B254","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.2147\/IJN.S506793","article-title":"Intranasal delivery of BACE1 siRNA and berberine via engineered stem cell exosomes for the treatment of Alzheimer's disease","volume":"20","author":"Sun","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"B255","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/acs.molpharmaceut.5c00761","article-title":"Nose-to-brain delivery of donepezil hydrochloride via oleic acid-conjugated PAMAM G4 dendrimers for the treatment of Alzheimer's-like dementia","volume":"23","author":"Suthar","year":"2025","journal-title":"Mol. Pharm."},{"key":"B256","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1124\/dmd.108.024745","article-title":"Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport","volume":"37","author":"Syvanen","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"B258","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer's disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"key":"B259","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.apsb.2021.09.029","article-title":"The effect of drug loading and multiple administration on the protein corona formation and brain delivery property of PEG-PLA nanoparticles","volume":"12","author":"Tang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B260","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/pharmaceutics14020411","article-title":"Delivery of intravenously administered antibodies targeting Alzheimer's disease-relevant tau species into the brain based on receptor-mediated transcytosis","volume":"14","author":"Tashima","year":"2022","journal-title":"Pharmaceutics"},{"key":"B261","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/0115672050288659240229080535","article-title":"Nanostructured lipid carriers of donepezil hydrochloride for the treatment of Alzheimer's disease","volume":"21","author":"Tekade","year":"2024","journal-title":"Curr. Alzheimer Res."},{"key":"B262","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","article-title":"Alzheimer's disease: exploring the landscape of cognitive decline","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"B263","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"B265","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"B266","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11064-005-6963-8","article-title":"Cellular stress reactions as putative cholinergic links in Alzheimer's disease","volume":"30","author":"Toiber","year":"2005","journal-title":"Neurochem. Res."},{"key":"B267","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0271678X251361997","article-title":"Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer's mouse model","volume":"46","author":"Torres","year":"2026","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B268","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1016\/j.biomaterials.2007.08.011","article-title":"Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons","volume":"28","author":"Townsend","year":"2007","journal-title":"Biomaterials"},{"key":"B269","doi-asserted-by":"publisher","first-page":"e0130442","DOI":"10.1371\/journal.pone.0130442","article-title":"Nano-drugs based on nano sterically stabilized liposomes for the treatment of inflammatory neurodegenerative diseases","volume":"10","author":"Turjeman","year":"2015","journal-title":"PLoS One"},{"key":"B270","first-page":"375","article-title":"Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems","volume":"61","author":"\u00dcner","year":"2006","journal-title":"Pharmazie"},{"key":"B271","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.7150\/thno.34509","article-title":"Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans","volume":"9","author":"Valic","year":"2019","journal-title":"Theranostics"},{"key":"B272","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B273","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s11095-010-0291-7","article-title":"In vivo methods to study uptake of nanoparticles into the brain","volume":"28","author":"Van Rooy","year":"2011","journal-title":"Pharm. Res."},{"key":"B274","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00204-021-03115-y","article-title":"Differences in P-glycoprotein activity in human and rodent blood\u2013brain barrier assessed by mechanistic modelling","volume":"95","author":"Verscheijden","year":"2021","journal-title":"Arch. Toxicol."},{"key":"B275","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"B276","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","article-title":"Amyloid beta-protein and beyond: the path forward in Alzheimer's disease","volume":"61","author":"Walsh","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"B277","doi-asserted-by":"publisher","first-page":"27127","DOI":"10.1021\/acsami.4c02825","article-title":"Multifunctional nanocarrier for synergistic treatment of Alzheimer's disease by inhibiting \u03b2-amyloid aggregation and scavenging reactive oxygen species","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B278","doi-asserted-by":"publisher","first-page":"e2200825","DOI":"10.1002\/mnfr.202200825","article-title":"Antarctic krill oil exhibited synergistic effects with nobiletin and theanine on regulating ligand-specific receptor-mediated transcytosis in blood-brain barrier by inhibiting alkaline phosphatase in SAMP8 mice","volume":"67","author":"Wang","year":"","journal-title":"Mol. Nutr. Food Res."},{"key":"B279","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1021\/acschemneuro.3c00401","article-title":"Zein-based nanoparticles improve the therapeutic efficacy of a TrkB agonist toward Alzheimer's disease","volume":"14","author":"Wang","year":"","journal-title":"ACS Chem. Neurosci."},{"key":"B280","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1021\/acsabm.5c00267","article-title":"Dual-targeting protein-based delivery system for enhanced drug therapy of neurodegenerative disorders","volume":"8","author":"Wang","year":"","journal-title":"ACS Appl. Bio Mater."},{"key":"B281","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1002\/alz.70048","article-title":"Tau degradation in Alzheimer's disease: mechanisms and therapeutic opportunities","volume":"21","author":"Wang","year":"","journal-title":"Alzheimers. Dement."},{"key":"B282","doi-asserted-by":"publisher","first-page":"1801002","DOI":"10.1002\/adhm.201801002","article-title":"Nanocarriers and their loading strategies","volume":"8","author":"Wang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"B283","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1039\/D0BM02221G","article-title":"Strategies for the design of nanoparticles: starting with long-circulating nanoparticles, from lab to clinic","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"key":"B284","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B285","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"B286","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s003969900257","article-title":"Novel lipid-based colloidal dispersions as potential drug administration systems\u2013expectations and reality","volume":"278","author":"Westesen","year":"2000","journal-title":"Colloid Polym. Sci."},{"key":"B287","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J. Control. Release"},{"key":"B288","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1039\/C4NR05982D","article-title":"Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition","volume":"7","author":"Winzen","year":"2015","journal-title":"Nanoscale"},{"key":"B289","doi-asserted-by":"publisher","first-page":"862369","DOI":"10.3389\/fneur.2022.862369","article-title":"Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer's disease","volume":"13","author":"Withington","year":"2022","journal-title":"Front. Neurol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/pharmaceutics14040836","article-title":"Lipid-based nanocarriers for neurological disorders: a review of the state-of-the-art and therapeutic success to date","volume":"14","author":"Witika","year":"2022","journal-title":"Pharmaceutics"},{"key":"B291","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: unraveling the potential for Alzheimer's disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"B292","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jphp.12836","article-title":"Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease","volume":"70","author":"Wong","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"B293","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B294","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/pharmaceutics17060775","article-title":"Intranasal drug delivery technology in the treatment of central nervous system diseases: challenges, advances, and future research directions","volume":"17","author":"Wu","year":"2025","journal-title":"Pharmaceutics"},{"key":"B295","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-122419","article-title":"Brain transit and ameliorative effects of intranasally delivered anti-amyloid-beta oligomer antibody in 5XFAD mice","volume":"35","author":"Xiao","year":"2013","journal-title":"J. Alzheimers. Dis."},{"key":"B296","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1021\/acs.biomac.6b00863","article-title":"Amorphous silk nanofiber solutions for fabricating silk-based functional materials","volume":"17","author":"Xiaodan","year":"2016","journal-title":"Biomacromolecules"},{"key":"B297","doi-asserted-by":"publisher","first-page":"e101143","DOI":"10.1136\/gpsych-2023-101143","article-title":"Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I\/II clinical trial","volume":"36","author":"Xie","year":"2023","journal-title":"Gen. Psychiatr."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","article-title":"Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats","volume":"33","author":"Xin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B299","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijpharm.2006.03.046","article-title":"Electrospray encapsulation of water-soluble protein with polylactide: effects of formulations on morphology, encapsulation efficiency and release profile of particles","volume":"320","author":"Xu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"B300","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1134\/S1990747822030096","article-title":"Principles and problems of exosome isolation from biological fluids","volume":"16","author":"Yakubovich","year":"2022","journal-title":"Biochem. (Mosc.) Suppl. Ser. A Membr. Cell Biol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.3390\/ijms26136271","article-title":"Recent advances in antibody therapy for Alzheimer's disease: focus on bispecific antibodies","volume":"26","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B302","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","article-title":"Large soluble oligomers of amyloid beta-protein from alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate","volume":"37","author":"Yang","year":"2017","journal-title":"J. Neurosci."},{"key":"B303","doi-asserted-by":"publisher","first-page":"104942","DOI":"10.1016\/j.jff.2022.104942","article-title":"Silk fibroin hydrolysate improves memory impairment via multi-target function","volume":"89","author":"Yao","year":"2022","journal-title":"J. Funct. Foods"},{"key":"B304","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1080\/21691401.2017.1394872","article-title":"Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box\u2013Behnken design, in vitro and in vivo evaluation","volume":"46","author":"Yasir","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B305","doi-asserted-by":"publisher","first-page":"110995","DOI":"10.1016\/j.jbc.2025.110995","article-title":"A humanized transferrin receptor 1-transferrin model supports functional iron homeostasis and therapeutic delivery across the blood\u2013brain barrier","volume":"302","author":"Yesiltepe","year":"2026","journal-title":"J. Biol. Chem."},{"key":"B306","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.7150\/thno.81860","article-title":"Engineered mesenchymal stem cell-derived extracellular vesicles: a state-of-the-art multifunctional weapon against Alzheimer's disease","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"key":"B307","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/pharmaceutics13030429","article-title":"Silk fibroin: an ancient material for repairing the injured nervous system","volume":"13","author":"Yonesi","year":"2021","journal-title":"Pharmaceutics"},{"key":"B308","doi-asserted-by":"publisher","first-page":"2304373","DOI":"10.1002\/adhm.202304373","article-title":"The role of reactive oxygen species in Alzheimer's disease: from mechanism to biomaterials therapy","volume":"13","author":"Yu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"B309","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.xphs.2018.10.037","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"108","author":"Yuan","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"B310","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","article-title":"Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model","volume":"21","author":"Yusuf","year":"2013","journal-title":"J. Drug Target."},{"key":"B311","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/1061186X.2020.1817041","article-title":"Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery","volume":"29","author":"Zameer","year":"2021","journal-title":"J. Drug Target."},{"key":"B312","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40005-022-00584-w","article-title":"Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: reviewing two decades of research","volume":"52","author":"Zeb","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"B313","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1007\/s13204-022-02638-9","article-title":"The impacts of curcumin on learning memory function in Alzheimer's disease under the poly lactic-co-glycolic acid nanoparticle drug carrier","volume":"13","author":"Zeng","year":"2023","journal-title":"Appl. Nanosci."},{"key":"B314","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Zhang","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"B315","doi-asserted-by":"publisher","first-page":"20210115","DOI":"10.1002\/EXP.20210115","article-title":"Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases","volume":"1","author":"Zhang","year":"2021","journal-title":"Exploration"},{"key":"B316","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"B317","doi-asserted-by":"publisher","first-page":"119822","DOI":"10.1016\/j.biomaterials.2020.119822","article-title":"Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease","volume":"237","author":"Zhou","year":"2020","journal-title":"Biomaterials"},{"key":"B318","doi-asserted-by":"publisher","first-page":"e1695","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide\u2013drug conjugates to overcome the blood\u2013brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1810486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:34:55Z","timestamp":1778736895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1810486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":318,"alternative-id":["10.3389\/fnins.2026.1810486"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1810486","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"1810486"}}